Accord Healthcare UK Ltd has announced that Disulfiram, an alcohol deterrent compound, will be made available to all UK pharmacists and dispensing doctors for prescription to suitable patients. Following its launch... Read More
Author: pharmacybiz
The General Pharmaceutical Council (GPhC) has published updated guidance on online pharmacy services in Great Britain, introducing additional safeguards to prevent unsafe supply of high-risk medicines, including weight loss injections. Under... Read More
The Lords Food, Diet and Obesity Committee has expressed disappointment with the government’s response to its recommendations for tackling the obesity crisis. In October 2024, the Committee released its report, Recipe... Read More
The Royal College of GPs (RCGP) has warned that patients in deprived areas could face even greater difficulty accessing GP services if funding for the Targeted Enhanced Recruitment Scheme (TERS)... Read More
NPA Insurance, a wholly owned subsidiary of the National Pharmacy Association (NPA), has updated its professional indemnity policy for locum pharmacists to better support their expanding roles in healthcare. The enhanced... Read More
Haleon is enhancing its research and development (R&D) capabilities and accelerating its new product innovation pipeline with a $54 million (£43.49 million) investment in its global R&D centre of excellence... Read More
Marking Pharmacy First’s first anniversary in England, the Company Chemists’ Association (CCA) has called on policymakers to expand the service, highlighting that there’s still “significant room for growth.” In a report... Read More
The Royal Pharmaceutical Society (RPS) has expressed a neutral stance on assisted dying, while emphasising the importance of certain safeguards in any proposed legislation. In particular, they have urged the Bill... Read More
Scotland’s first minister, John Swinney, has announced the expansion of the NHS Pharmacy First Service as part of the government’s strategy to shift more care into communities. However, Numark chairman Harry... Read More
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has initiated a review of semaglutide-containing medicines after concerns were raised regarding a potential increased risk of non-arteritic anterior ischemic... Read More